This statistic describes the global pharmaceutical sales in from 2014 to 2016, sorted by regional submarkets. As of Q3 2016, total pharmaceutical sales in the United States was estimated to reach around 446 billion U.S. dollars in that year.
World pharmaceutical sales by region
The pharmaceutical industry is best known for manufacturing pharmaceutical drugs which aim to diagnose, cure, treat, or prevent diseases. The pharmaceutical sector represents a huge industry, with the global market valuing in at nearly one trillion U.S. dollars. The best known top global pharmaceutical companies are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Accordingly, North America and Europe are still the largest global submarkets for pharmaceuticals.
In 2016, the United States was still the largest single pharmaceutical market, generating almost 450 billion U.S. dollars of revenue. Europe was responsible for generating around 200 billion U.S. dollars. These two markets, together with Japan, Canada and Australia, form the so-called established (or developed) markets. The rest of the global pharmaceutical revenue is mainly from emerging markets which include countries like China, Russia, Brazil and India. In fact, these emerging markets show the fastest increase in pharmaceutical sales. Latin America and the Indian Subcontinent are the only world regions for which a pharmaceutical compound annual growth rate higher than 10 percent is predicted up until 2018.
World pharmaceutical sales by region
The pharmaceutical industry is best known for manufacturing pharmaceutical drugs which aim to diagnose, cure, treat, or prevent diseases. The pharmaceutical sector represents a huge industry, with the global market valuing in at nearly one trillion U.S. dollars. The best known top global pharmaceutical companies are Pfizer, Merck and Johnson & Johnson from the U.S., Novartis and Roche from Switzerland, Sanofi from France, etc. Accordingly, North America and Europe are still the largest global submarkets for pharmaceuticals.
In 2016, the United States was still the largest single pharmaceutical market, generating almost 450 billion U.S. dollars of revenue. Europe was responsible for generating around 200 billion U.S. dollars. These two markets, together with Japan, Canada and Australia, form the so-called established (or developed) markets. The rest of the global pharmaceutical revenue is mainly from emerging markets which include countries like China, Russia, Brazil and India. In fact, these emerging markets show the fastest increase in pharmaceutical sales. Latin America and the Indian Subcontinent are the only world regions for which a pharmaceutical compound annual growth rate higher than 10 percent is predicted up until 2018.
